BXP, Inc. vs Crown Castle Inc. — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
BXP
Earnings growing 66% year-over-year.
⚠ weak profitability metrics drag quality score.
CCI
Valuation metrics in line with sector peers.
⚠ revenue declining 5% year-over-year.
Analyst Consensus
HOLD
Target $69.40 (+16.9%)
20 analysts
HOLD
Target $98.72 (+10.6%)
20 analysts
Fundamentals
BXP
CCI
29.8×
Trailing P/E
37.7×
28.5×
Forward P/E
30.2×
9.9%
Profit Margin
25.1%
56.7%
Gross Margin
73.8%
5.5%
ROE
—
5.6%
Revenue Growth
-4.8%
65.5%
Earnings Growth
—
1.05
Beta
0.96
—
Price / Book
—
$10.5B
Market Cap
$39.0B
$50 – $79
52-Week Range
$76 – $116
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →